Drug Shortage Report for TEVA-AMPHETAMINE XR

Last updated on 2023-07-05 History
Report ID 195891
Drug Identification Number 02439239
Brand name TEVA-AMPHETAMINE XR
Common or Proper name TEVA-AMPHETAMINE XR
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MIXED SALTS AMPHETAMINE
Strength(s) 5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-19
Estimated end date 2023-07-20
Actual end date 2022-07-05
Shortage status Avoided shortage
Updated date 2023-07-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2023-07-05 English Compare
v2 2023-06-20 French Compare
v1 2023-06-20 English Compare

Showing 1 to 3 of 3